Title: The B3A2 junction type of the BCR-ABL oncogene is a favorable prognostic factor for a complete response to interferon treatment in patients with chronic myeloid leukemia (CML)
Authors: Posthuma, EFM
de Paus, R
Kluin-Nelemans, H
Beverloo, B
Mensink, E
Meijerink, JPP
Smit, B
Hagemeijer-Hausman, Anne
Wiliemze, R
Falkenburg, JHF #
Issue Date: Nov-1998
Publisher: W b saunders co
Host Document: Blood vol:92 issue:10 pages:93A-93A
Conference: ASH 40th Annual Meeting location:Miami Beach, Florida date:December 4-8, 1998
ISSN: 0006-4971
Publication status: published
KU Leuven publication type: IMa
Appears in Collections:Department of Human Genetics - miscellaneous
# (joint) last author

Files in This Item:

There are no files associated with this item.


All items in Lirias are protected by copyright, with all rights reserved.